A new mouse ASF-LL model of adult T-lymphoma/leukemia (ATLL) in humans was characterized by cytological, histopathological, and flow cytometry analyses. Encouraging similarities of morphological, pathological, and clinical signs were found. These included characteristic flower appearance of leukemic cells, lymphadenopathy and hepatosplenomegaly, multiple growths in the skin, urogenital tissues, lungs and pituitary gland, CD4+CD25+ phenotype of the majority of tumor cells that were selectin-L positive, a rapid clinical course, and poor response to standard chemotherapy. Plant peptides obtained from the traditional Russian herbal medicine have gradually gained considerable attention as a new source of anticancer drugs. We have tested antitumor activity of a peptide extract PE-PM obtained from a mixture of Chelidonium majus L., Inula helenium L., Equisetum arvense L. and Inonotus obliquus in new mouse T-lymphoma/leukemia model ASF-LL. Distinct antitumor activity of two local injections of the peptide extract PE-PM was detected by tumor growth inhibition and survival improvement of 33% of recipients bearing intraperitoneal form of ASF-LL.
Chaadaeva A.V., Tepkeeva I.I., Moiseeva E.V., Svirshchevskaya E.V., Demushkin V.P. (2009) Antitumor activity of the plant remedy peptide extract PE-PM in a new mouse T-lymphoma/leukemia model. Biomeditsinskaya Khimiya, 55(1), 81-88.
Chaadaeva A.V. et al. Antitumor activity of the plant remedy peptide extract PE-PM in a new mouse T-lymphoma/leukemia model // Biomeditsinskaya Khimiya. - 2009. - V. 55. -N 1. - P. 81-88.
Chaadaeva A.V. et al., "Antitumor activity of the plant remedy peptide extract PE-PM in a new mouse T-lymphoma/leukemia model." Biomeditsinskaya Khimiya 55.1 (2009): 81-88.
Chaadaeva, A. V., Tepkeeva, I. I., Moiseeva, E. V., Svirshchevskaya, E. V., Demushkin, V. P. (2009). Antitumor activity of the plant remedy peptide extract PE-PM in a new mouse T-lymphoma/leukemia model. Biomeditsinskaya Khimiya, 55(1), 81-88.
References
Callens C., Moura I.C., Lepelletier Y., Coulon S., Renand A., Dussiot M., Ghez D., Benhamou M., Monteiro R.C., Bazarbachi A., Hermine O. (2008) Leukemia, 22(1), 42-48. Scholar google search
Den Otter W., Steerenberg P.A., Van der Laan J.W. (2002) Regul. Toxicol. Pharmacol., 35(2 Pt 1), 266-272. Scholar google search
Moiseeva E.V., Merkulova I.B., Bijleveld C., Koten J-W., Miroshnikov A.I., Den Otter W.(2003) Cancer Immunol. Immunother., 52, 487-496. Scholar google search
Moiseeva E. (2005) Original approaches to test anti-breast cancer drugs in a novel set of mouse models. Pathobiology, Utrecht University, 191 p.p., http://igitur-archive.library.uu.nl/dissertations/2005-1130-200033/index.htm . Scholar google search
Тепкеева И.И., Чаадаева А.В., Кесслер Ю.В., Моисеева Е.В., Демушкин В.П. (2008) Российский иммунологический журнал, 2(11), 73-75. Scholar google search
Гублер Е.В., Генкин А.А. (1973) Критерий U Вилкoксона-Манна-Уитни. Применение непараметрических критериев статистики в медико-биологических исследованиях, М., Наука, 72-75. Scholar google search
Инджия Л.В., Яковлева Л.А., Чикобава М.Г., Валентян М., Лапин Б.А., Кларк Е. (1990) Вестник Академии Медицинских Наук СССР, 9, 21-27. Scholar google search
Svangard E., Burman R., Gunasekera S., Lovborg H., Gullbo J., Goransson U. (2007) J. Nat. Prod., 70, 643-647. Scholar google search
Den Otter W., Jacobs J.J., Battermann J.J., Hordijk G.J., Krastev Z., Moiseeva E.V., Stewart R.J., Ziekman P.G., Koten J.W. (2008) Cancer Immunol. Immunother., [Epub ahead of print]. Scholar google search
Lissoni P., Bordin V., Vaghi M., Fumagalli L., Bordoni A., Mengo S., Bucovec R., Fumagalli E., Malugani F., Ardizzoia A., Giani L., Gardani G.S., Tancini G. (2002) Anticancer Res., 22(2B), 1061-1064. Scholar google search
